NCT01351493

Brief Summary

The purpose of this study is to evaluate the efficacy of nitric oxide gel for pressure sore recovery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jul 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 11, 2011

Completed
1.1 years until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

July 11, 2012

Status Verified

July 1, 2012

Enrollment Period

1 year

First QC Date

May 9, 2011

Last Update Submit

July 10, 2012

Conditions

Keywords

pressure sorenitric oxide

Outcome Measures

Primary Outcomes (1)

  • Pressure ulcer stage assessment after the endpoint of intervention period

    12 weeks

Secondary Outcomes (1)

  • The secondary efficacy end point will be pressure sore scale assessment of improvement.

    12 weeks

Study Arms (2)

Nitric oxide gel

ACTIVE COMPARATOR
Drug: Nitric Oxide

placebo

PLACEBO COMPARATOR
Drug: placebo

Interventions

Nitric Oxide Gel, once or twice per day, 12weeks

Nitric oxide gel

placebo Gel, once or twice per day, 12weeks

placebo

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects who live in nursing home
  • Clinical diagnosis of pressure sore \> grade II(grade developed by NPAUP)
  • without acute illness required hospitalization
  • able to understanding and signed the Inform Consent Form after detailed description of the treatment and potential risks and benefits

You may not qualify if:

  • diagnosis of cancer and still on active therapies
  • on other medications with pharmacological actions may lead to excessive formation of nitric oxide, or may accentuate drug effects due to excessive formation of nitric oxide
  • with systemic infection and need systemic antibiotics
  • pressure sore local infection and need topic antibiotic(for pressure sore wound)
  • with any known allergic reaction to any ingredient in the 2 gel prescriptions
  • Subjects who have been enrolled into any other clinical study in the preceding 3 months prior to randomization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, Taichung, 404, Taiwan

RECRUITING

MeSH Terms

Conditions

Pressure Ulcer

Interventions

Nitric Oxide

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Reactive Nitrogen SpeciesFree RadicalsInorganic ChemicalsNitrogen OxidesNitrogen CompoundsOxidesOxygen CompoundsOrganic Chemicals

Study Officials

  • Chiu-Shong Liu, M.D.

    China Medical University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chiu-Shong Liu, MD.MSc.

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2011

First Posted

May 11, 2011

Study Start

July 1, 2012

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

July 11, 2012

Record last verified: 2012-07

Locations